Dundas & Wilson’s bonny U-turn

Sign in or register to continue reading.

Gain access to the latest news from The Lawyer.com, our jobs board, career insight and much more.

Register now to The Lawyer to access our latest news stories, read selected briefings from key firms and gain essential careers insight to help you make the most of your current and future roles.

Contact Us: if you have any questions regarding your subscription, call us on +44 (0)20 7292 3716 or email us at customerservices@thelawyer.com

Register now

Having problems?

Contact us on +44 (0)20 7292 3716 | email: customerservices@thelawyer.com

If you are looking for our Jobs site, please click here 

Latest Briefings

The Commercial Agents Regulations: a step behind the times?

By Alex Williamson The Commercial Agents (Council Directive) Regulations 1993 (the Regulations) are 25 years old this year. An evaluation by the European Commission concluded in 2015 that the underlying Commercial Agents Directive (the Directive) still met its objectives and functioned well. However, a recent Court of Appeal decision has shown that the legislation is struggling to […]

Exclusion clauses under the spotlight: UCTA reasonableness

By Perran Jervis In decisions handed down one day apart, the Court of Appeal concluded that a far-reaching exclusion clause which limited liability for negligence was reasonable under the Unfair Contract Terms Act 1977 (UCTA), whereas an exclusion clause in a lease (in the form of a non-reliance clause) was not. The decisions emphasise that […]

Currency, cost calculations and contractual clarity

Walker Morris’ Head of Commercial Dispute Resolution, Gwendoline Davies, highlights the importance of dealing comprehensively and clearly with matters of currency and calculation in cross-border contracts…

Belgian draft Trade Secrets Act: opportunities for the life sciences sector

On 8 June 2016, the EU Trade Secrets Directive was adopted. The main purpose of the Directive was to harmonise and enhance the protection of trade secrets EU-wide and to thus create an innovation-friendly environment for businesses. The EU Member States had to implement this Directive by 9 June 2018. Belgium missed the deadline, but […]

Recommended

Mourant Ozannes tops list of offshore law firms advising FTSE companies

Mourant Ozannes advises significantly more FTSE 100 and FTSE 250 companies than any other offshore law firm, according to the latest rankings published by Adviser Rankings Ltd (ARL). The rankings show that Mourant Ozannes advises more FTSE 100 clients than all of its global competitors combined. The market capitalisation of Mourant Ozannes’ FTSE clients is […]

We predict: it won’t be quiet

We predict you’ll like this. Or at least you’re going to find it stimulating. Today’s issue of The Lawyer, our first back after the fabulous summer, is largely dedicated to a series of bold predictions about the future look, shape and feel of the legal market. And no, we haven’t just plucked them out of […]

Paul Wilson
6

Shakespeares continues Midlands growth with two new mergers

Shakespeares has expanded again through two bolt-on acquisitions as it continues in its bid to be a £50m mid-tier heavyweight by 2014. The firm has confirmed the addition of Leicester-based Marrons, first mooted in May (31 May 2013) while also tying up with Coventry-based Newsome Vaughan. Marrons is intended to boost Shakespeares’ planning and property […]

DLA Piper advises Arsenal Capital Partners in its aquisition of IFC

DLA Piper has advised Arsenal Capital Partners, a New York-based private equity firm that invests in middle-market specialty industrial and healthcare companies, in its acquisition of International Fiber Corporation (ICC). IFC is a supplier of cellulose‐based insoluble fibre products for glboal food and industrial applications. The company joins Arsenal Capital’s extensive portfolio of investments in the speciality […]

The future of DNA patents

By Lisa A Haile The US Supreme Court has ruled that certain patent claims owned by Myriad Genetics, the US biotech company that holds the patents covering a test for breast cancer-related genes (BRCA1 and BRCA2), are invalid as products of nature. The implications for this decision, handed down on 13 June, may not be […]

In-House & Private Practice Legal Jobs

Stay up-to-date with the latest opportunities on The Lawyer Careers. Each month, more than 8,000 legal roles are added to our site - we'll bring you the best opportunities out there.

Get Started

Register now to The Lawyer to access our latest news stories, read selected briefings from key firms and gain essential careers insight to help you make the most of your current and future roles.

Contact Us: if you have any questions regarding your subscription, call us on +44 (0)20 7292 3716 or email us at customerservices@thelawyer.com

Register now

Having problems?

Contact us on +44 (0)20 7292 3716 | email: customerservices@thelawyer.com

If you are looking for our Jobs site, please click here